Crescita Therapeutics (TSE:CTX) Trading Down 8.2% – Should You Sell?

Crescita Therapeutics Inc. (TSE:CTX) shares were down 8.2% during mid-day trading on Thursday . The stock traded as low as C$0.45 and last traded at C$0.45. Approximately 100,878 shares were traded during mid-day trading, an increase of 162% from the average daily volume of 38,452 shares. The stock had previously closed at C$0.49.

Crescita Therapeutics Stock Performance

The firm has a market cap of C$9.12 million, a price-to-earnings ratio of 24.50 and a beta of -0.26. The stock has a 50 day moving average of C$0.48 and a 200 day moving average of C$0.47. The company has a quick ratio of 2.29, a current ratio of 2.70 and a debt-to-equity ratio of 5.77.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.